Cedillo LM, Velázquez López JD, Bonilla EC, Hernández RH, Jessica SG. BRAF Wild-Type Melanomas with NF1 Mutations: Implications for MEK Inhibitor Therapy in Specific Molecular Subgroups. International Journal Of Medical Science And Clinical Research Studies [Internet]. 2025Sep.20 [cited 2026Oct.26];5(09):1610-4. Available from: https://www.ijmscrs.com/index.php/ijmscrs/article/view/2483